Describes a novel approach using a percutaneous left ventricular assist device to enable mapping and ablation of hypotensive ventricular tachycardia.
Answers are grounded in this paper and cite their sources.
May enable ablation of otherwise unmappable hypotensive VT; hypothesis-generating and should not yet change practice.
Ventricular tachycardia (VT) in the setting of structural heart disease is challenging to treat with percutaneous catheter ablation due to the presence of complex substrate, multiple morphologies, hemodynamic instability, and epicardial circuits. When substrate-based approaches fail, however, it may be impossible to map and ablate hemodynamically unstable arrhythmias. We describe a novel approach to endocardial and epicardial mapping and ablation of hypotensive VT using a percutaneous left ventricular assist device in the electrophysiology laboratory, permitting near-surgical access to cardiac structures.
No takes yet. Share an insight, caveat, or question.
Friedman et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: